Mehta, Arpan R.Walters, RachelWaldron, Fergal M.Pal, SuvankarSelvaraj, Bhuvaneish T.Macleod, Malcolm R.Hardingham, Giles E.Chandran, SiddharthanGregory, Jenna2022-08-022022-08-022019-08-06Mehta, A R, Walters, R, Waldron, F M, Pal, S, Selvaraj, B T, Macleod, M R, Hardingham, G E, Chandran, S & Gregory, J 2019, 'Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis : a systematic review and meta-analysis', Brain Communications, vol. 1, no. 1, fcz009. https://doi.org/10.1093/braincomms/fcz009, https://doi.org/10.1093/braincomms/fcz0092632-1297ORCID: /0000-0003-3337-4079/work/112145060ORCID: /0000-0003-2622-0776/work/118591687https://hdl.handle.net/2164/18989Funding A.R.M. is a Lady Edith Wolfson Clinical Fellow and is jointly funded by the Medical Research Council and the Motor Neurone Disease Association (MR/R001162/1). He also acknowledges support from the Rowling Scholars scheme, administered by the Anne Rowling Regenerative Neurology Clinic. Both the Chandran and Hardingham laboratories are supported by the Euan MacDonald Centre and the UK Dementia Research Institute partner funders: the Medical Research Council, Alzheimer’s Research UK and the Alzheimer’s Society. J.M.G is funded by a starter grant for clinical lecturers from the Academy of Medical Sciences (AMS: 210JMG 3102 R45620)141818245engsystematic reviewmeta-analysisamyotrophic lateral sclerosismitochondriamodellingRC0321 Neuroscience. Biological psychiatry. NeuropsychiatryMedical Research Council (MRC)MR/R001162/1Supplementary Datafcz009_Supplementary_Data - zip fileRC0321Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis : a systematic review and meta-analysisJournal article10.1093/braincomms/fcz009http://dx.doi.org/10.1093/braincomms/fcz00911